Experiment: 2MFJ

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1 mM [U-100% 15N] Blo t 19-4, 50 mM potassium phosphate-5, 100 mM sodium chloride-6	90% H2O/10% D2O		6.0	ambient	295
2	2D 1H-13C HSQC	1 mM [U-100% 13C; U-100% 15N] Blo t 19-1, 50 mM potassium phosphate-2, 100 mM sodium chloride-3	90% H2O/10% D2O		6.0	ambient	295
3	3D HNCO	1 mM [U-100% 13C; U-100% 15N] Blo t 19-1, 50 mM potassium phosphate-2, 100 mM sodium chloride-3	90% H2O/10% D2O		6.0	ambient	295
4	3D HN(CA)CO	1 mM [U-100% 13C; U-100% 15N] Blo t 19-1, 50 mM potassium phosphate-2, 100 mM sodium chloride-3	90% H2O/10% D2O		6.0	ambient	295
5	3D HNCA	1 mM [U-100% 13C; U-100% 15N] Blo t 19-1, 50 mM potassium phosphate-2, 100 mM sodium chloride-3	90% H2O/10% D2O		6.0	ambient	295
6	3D HNCACB	1 mM [U-100% 13C; U-100% 15N] Blo t 19-1, 50 mM potassium phosphate-2, 100 mM sodium chloride-3	90% H2O/10% D2O		6.0	ambient	295
7	3D CBCA(CO)NH	1 mM [U-100% 13C; U-100% 15N] Blo t 19-1, 50 mM potassium phosphate-2, 100 mM sodium chloride-3	90% H2O/10% D2O		6.0	ambient	295
8	3D HNHA	1 mM [U-100% 13C; U-100% 15N] Blo t 19-1, 50 mM potassium phosphate-2, 100 mM sodium chloride-3	90% H2O/10% D2O		6.0	ambient	295
9	3D HCCH-COSY	1 mM [U-100% 13C; U-100% 15N] Blo t 19-1, 50 mM potassium phosphate-2, 100 mM sodium chloride-3	90% H2O/10% D2O		6.0	ambient	295
10	3D HCCH-TOCSY	1 mM [U-100% 13C; U-100% 15N] Blo t 19-1, 50 mM potassium phosphate-2, 100 mM sodium chloride-3	90% H2O/10% D2O		6.0	ambient	295
11	2D-hbCBcgcdHD	1 mM [U-100% 13C; U-100% 15N] Blo t 19-1, 50 mM potassium phosphate-2, 100 mM sodium chloride-3	90% H2O/10% D2O		6.0	ambient	295
12	2D-hbCBcgcdceHE	1 mM [U-100% 13C; U-100% 15N] Blo t 19-1, 50 mM potassium phosphate-2, 100 mM sodium chloride-3	90% H2O/10% D2O		6.0	ambient	295
13	2D-TOCSY	1 mM Blo t 19-7, 50 mM potassium phosphate-8, 100 mM sodium chloride-9	90% H2O/10% D2O		6.0	ambient	295
14	3D 1H-15N TOCSY	1 mM [U-100% 15N] Blo t 19-4, 50 mM potassium phosphate-5, 100 mM sodium chloride-6	90% H2O/10% D2O		6.0	ambient	295
15	2D 1H-1H NOESY	1 mM Blo t 19-7, 50 mM potassium phosphate-8, 100 mM sodium chloride-9	90% H2O/10% D2O		6.0	ambient	295
16	3D 1H-13C NOESYHSQC	1 mM [U-100% 13C; U-100% 15N] Blo t 19-1, 50 mM potassium phosphate-2, 100 mM sodium chloride-3	90% H2O/10% D2O		6.0	ambient	295
17	3D 1H-15N NOESYHSQC	1 mM [U-100% 13C; U-100% 15N] Blo t 19-1, 50 mM potassium phosphate-2, 100 mM sodium chloride-3	90% H2O/10% D2O		6.0	ambient	295
18	2D 1H-15N IPAP HSQC	1 mM [U-100% 15N] Blo t 19-10, 50 mM potassium phosphate-11, 100 mM sodium chloride-12, 15 mg/ml Pf1 phage-13	90% H2O/10% D2O		6.0	ambient	295

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	500
2	Bruker	AVANCE	600
3	Bruker	AVANCE	800
4	Bruker	AVANCE	850

NMR Refinement
Method	Details	Software
torsion angle dynamics, DGSA-distance geometry simulated annealing	Initial structure ensemble was calculated by semi-automated NOESY assignment by CYANA. The assignments were manually verified in Sparky and final structure annealing was performed in CYANA. Structure and restraints from CYANA were imported in Xplor-NIH for explicit water refinement.	TopSpin

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	400
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Additional NMR Experimental Information
Details	NMR data was acquired at 295K using Shigemi NMR tubes.

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	TopSpin	3.0	Bruker Biospin
2	processing	TopSpin	3.0	Bruker Biospin
3	chemical shift assignment	Sparky		Goddard
4	peak picking	Sparky		Goddard
5	structure solution	CYANA	3.9	Guntert, Mumenthaler and Wuthrich
6	geometry optimization	CYANA	3.9	Guntert, Mumenthaler and Wuthrich
7	validation	PSVS	1.5	Bhattacharya and Montelione
8	refinement	X-PLOR NIH	2.34	Schwieters, Kuszewski, Tjandra and Clore
9	refinement	CYANA		Guntert, Mumenthaler and Wuthrich

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.